SCHEMBL5586172

SCHEMBL5586172

C=CCN(C(=O)C(F)(F)F)C(=O)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.32
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1231260 0.81 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2RAB9A
SCHEMBL7864386 0.77 CHRM2 (0.38) ALDH1A1SMN1; SMN2
SCHEMBL28937818 0.73 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2RAB9A
SCHEMBL9741277 0.73 ALDH1A1 (0.31) ALDH1A1
SCHEMBL1257402 0.71 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2
SCHEMBL169927 0.69 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2
SCHEMBL28433379 0.68 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL28479283 0.68 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2RAB9A
SCHEMBL11125801 0.67 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2
SCHEMBL7044812 0.67 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007091817-A1 ANION RECEPTOR, AND ELECTROLYTE USING THE SAME KIM HEE JUNG (KR) 2007-08-16 WO claimed
EP-4549444-A1 NOVEL ANIONIC RECEPTOR COMPOUND AND ELECTROLYTE COMPRISING SAME Zain Energy Inc. (KR) 2025-05-07 EP disclosed
EP-4549443-A1 NOVEL ANION RECEPTOR COMPOUND AND ELECTROLYTE CONTAINING SAME Zain Energy Inc. (KR) 2025-05-07 EP disclosed
US-20240162487-A1 NOVEL ANION RECEPTOR AND ELECTROLYTE COMPRISING SAME ZAYIN CHEMICAL CO., LTD. (KR) 2024-05-16 US disclosed
WO-2024005524-A1 NOVEL ANION RECEPTOR COMPOUND AND ELECTROLYTE CONTAINING SAME 자인에너지 주식회사 2024-01-04 WO disclosed
WO-2024005522-A1 NOVEL ANIONIC RECEPTOR COMPOUND AND ELECTROLYTE COMPRISING SAME 자인에너지 주식회사 2024-01-04 WO disclosed
CN-117157795-A Novel anion receptor and electrolyte comprising the same 自人新能有限公司 2023-12-01 CN disclosed
WO-2022177110-A1 NOVEL ANION RECEPTOR AND ELECTROLYTE COMPRISING SAME 자인케미칼 주식회사 2022-08-25 WO disclosed
WO-2007091867-A1 NOVEL CROSSLINKER AND SOLID POLYMER ELECTROLYTE USING THE SAME KIM HEE JUNG (KR) 2007-08-16 WO disclosed
WO-2007091817-A1 ANION RECEPTOR, AND ELECTROLYTE USING THE SAME KIM HEE JUNG (KR) 2007-08-16 WO disclosed
WO-2006129992-A1 ANION RECEPTOR AND ELECTROLYTE USING THE SAME KIM HEE JUNG (KR) 2006-12-07 WO disclosed
WO-2006129991-A1 ANION RECEPTOR AND ELECTROLYTE USING THE SAME KIM HEE JUNG (KR) 2006-12-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240162487-A1 NOVEL ANION RECEPTOR AND ELECTROLYTE COMPRISING SAME SLC26A3, SLC26A4, TMEM109 ALDH1A1 2249/4885SMN1; SMN2 4439/4885RAB9A 515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.